Contents:
BPC-157: 10 mg
TB-500 (Thymosin Beta-4): 10 mg
 
 
Description:

This research-grade peptide blend combines two well-studied compounds—BPC-157, known for its tissue-protective and regenerative properties, and TB-500, recognized for its role in promoting cellular migration, reducing inflammation, and supporting systemic recovery. Together, they are studied for their potential synergistic effects in accelerating healing across muscular, connective, and nervous tissue systems.
 
Research Application:
 
Standard Protocol: 250–500 mcg of each peptide daily (total 500–1000 mcg/day)
Duration: 2–4 weeks depending on experimental goals
Route: Subcutaneous (Sub-Q) or intramuscular (IM) injection
Cycling: Some protocols recommend cycles with brief breaks to assess ongoing tissue response
 
Availability:
Purity: ≥99%
Form: Lyophilized powder for reconstitution
 
 
Disclaimer:
The statements made on this website have not been evaluated by the US Food and Drug Administration. These are not findings from Raina's Summit, but instead publicly available studies. This product is for research purposes only.